Nanomedicines and Vaccines
NANO-VAC
Margarita
Martín Andorra
Publicacions en què col·labora amb Margarita Martín Andorra (8)
2022
2021
-
Author Correction: MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia (Scientific Reports, (2018), 8, 1, (11628), 10.1038/s41598-018-29965-8)
Scientific Reports
-
Erratum: MYO1F Regulates IgE and MRGPRX2-Dependent Mast Cell Exocytosis (Journal of Immunology (2021) 206 (2277-2289) DOI: 10.4049/jimmunol.2001211)
Journal of Immunology
-
MYO1F regulates IgE and MRGPRX2-dependent mast cell exocytosis
Journal of Immunology, Vol. 206, Núm. 10, pp. 2277-2289
-
The multifaceted mas‐related g protein‐coupled receptor member x2 in allergic diseases and beyond
International Journal of Molecular Sciences, Vol. 22, Núm. 9
2018
-
MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia
Scientific Reports, Vol. 8, Núm. 1
2017
-
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells
Scientific Reports, Vol. 7, Núm. 1
2016
-
Comparable actions of omalizumab on mast cells and basophils
Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 92-102